A comparative analysis of methyl prednisone pulse versus orthoclone therapy in the management of acute cellular rejection.
Nampoory
M R
MR
Department of Medicine, University of Kuwait, Safat, Kuwait.
Johny
K V
KV
Costandi
J N
JN
al-Muzairai
I M
IM
Gupta
R K
RK
Nair
M P
MP
Samhan
M
M
al-Mousawi
M
M
D000328:Adult; D003404:Creatinine / Q000097:blood; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D019520:Living Donors; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use*; D016853:Muromonab-CD3 / Q000627:therapeutic use*; D012189:Retrospective Studies; D014019:Tissue Donors
D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D003404:Creatinine; D008775:Methylprednisolone